{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_cf81dba1c68df3ac02de0ae45b4422b7c8c4775ed6034447632b1de7438efcc1","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_cf81dba1c68df3ac02de0ae45b4422b7c8c4775ed6034447632b1de7438efcc1","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"ee16835fe9e410d93fc90f224affc1b10ff1ac91f6d6c0962b2fd90ad9fb01b8","published":"Fri, 15 May 2026 00:00:00 -0400","receipt_hash":"ee16835fe9e410d93fc90f224affc1b10ff1ac91f6d6c0962b2fd90ad9fb01b8","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"ee16835fe9e410d93fc90f224affc1b10ff1ac91f6d6c0962b2fd90ad9fb01b8","observed_at":"2026-05-15T04:43:17.611638Z","parent_run_hash":"5c64f85625fabd323e9c4a1cf068c012fb88a248deda9a9ac702fb2f9799f2e5","published":"Fri, 15 May 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2605.13905v1 Announce Type: cross \nAbstract: Drug development and pharmacovigilance are frequently bottlenecked by legacy clinical reporting pipelines. These monolithic systems encode regulatory-grade logic but resist AI integration by producing opaque output with no machine-readable intermediate layer. Existing modernization approaches force a choice between full rewrites and incremental refactoring that preserves structural barriers. We present a non-destructive methodological framework achieving AI-driven pharmacoinformatics readiness without altering legacy source code. A metadata layer--comprising a bridge map, a typed Intermediate Representation (IR), and an orchestrator--wraps existing components and re-exposes their outputs as structured data consumable by LLMs. It enables optional incremental consolidation, replacing selected legacy components with metadata-configured core routines while the remainder operates unchanged. Validated on a 558-component SAS reporting library","title":"A Non-Destructive Methodological Framework for Modernizing Legacy Clinical Reporting Systems for AI-Driven Pharmacoinformatics: A SAS Case Study","url":"https://arxiv.org/abs/2605.13905","vendor":"arxiv_cs_ai"},"summary":"arXiv:2605.13905v1 Announce Type: cross \nAbstract: Drug development and pharmacovigilance are frequently bottlenecked by legacy clinical reporting pipelines. These monolithic systems encode regulatory-grade logic but resist AI integration by producing opaque output with no machine-readable intermediate layer. Existing modernization approaches force a choice between full rewrites and incremental refactoring that preserves structural barriers. We present a non-destructive methodological framework achieving AI-driven pharmacoinformatics readiness without altering legacy source code. A metadata layer--comprising a bridge map, a typed Intermediate Representation (IR), and an orchestrator--wraps existing components and re-exposes their outputs as structured data consumable by LLMs. It enables optional incremental consolidation, replacing selected legacy components with metadata-configured core routines while the remainder operates unchanged. Validated on a 558-component SAS reporting library","title":"A Non-Destructive Methodological Framework for Modernizing Legacy Clinical Reporting Systems for AI-Driven Pharmacoinformatics: A SAS Case Study","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-05-15T04:43:17Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2605.13905"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:3cae129bdb9d44c4866203090186a99190c52320aee0c022effe6e2286db1402c4232ab3adbb6ddddbaccee55c852aed8d5524ac7db4f79c103d5ea1978df60f","signer":"crovia.substrate","subject":{"observed_at":"2026-05-15T04:43:17Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2605.13905"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"c27a5b9710918e8ee9fb02c8cd177a50b8a7b69a0c7bcd91d78f59bcc159fe42","leaf_index":134508,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"8391573c7988f6397085ad1ef19e5d450d549291caf3b8f76fa72544145f24ee","side":"right"},{"sibling":"277219062ed7c6f6fa3b9862b668a0a5998538ed29e371616c64c8e6515f2cf4","side":"right"},{"sibling":"2905221e79bb979daab4d091b230d43d3018f0d0b90957bb0dc8306463ee7c39","side":"left"},{"sibling":"6f8ae88a38e41cd51369f8ca0774739acf65fb6fb6f8134439326dca86838fec","side":"left"},{"sibling":"a2f6456ada8e62d54bd97965f6ba5ca4e6bc352bb8c31b767a0e6f7453fae8ce","side":"right"},{"sibling":"621b9f34daa668dc5e3535facb5a01cc0190c3cd1989b306a638e48259c4a25a","side":"left"},{"sibling":"3262b224bf97e5bf6c5eed220ac5a0ff7a7c4e3b809039f633c552438e392b8c","side":"left"},{"sibling":"74f15de1b6fc788befd85007692dbe91c695ee2181b0b20f20e5a3e4147eaa67","side":"right"},{"sibling":"4711a7f4329f1874c3aa1ae93c336e1d4fa402bdd4b3d766c2a95304ea226882","side":"left"},{"sibling":"8ce2a4687a8ceb409df2e1cb10e44a610b21dc294e518a8550b6d1122335ca2b","side":"right"},{"sibling":"36672459e5ed50c64ee1842b69cb6d2eb682c2a04844555be8d124257571994a","side":"left"},{"sibling":"727783827652adfa99c455bd80a01bfb33836228e51068b4f654ef3da468ca69","side":"left"},{"sibling":"623194cd30880ed223e306737fdb111aa0d781751bfc47553c404a6af6aad2c4","side":"right"},{"sibling":"fc8f53ed42756907fb79ee19a4ed09f72c560e5302b3d98198b96bf1da635a4a","side":"right"},{"sibling":"d6607539da7ba39ec68be2d12f27ed6768766c745e3120fd915f88c5e288e07c","side":"right"},{"sibling":"b63408a424d27cd6a75e0fb155e69a58a328f41e9cb9dba1eddef9a5289cc7fd","side":"right"},{"sibling":"356fb36a4e188f03d7a05c54cd8789bdd40eda454b9bc9560f667acc08e6c4e0","side":"right"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":134886,"merkle_root":"c6c7ae28c065bced89e7f844216b073f1a7cc4b378db0d41a98bcd21b28066db","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260515T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-05-15T05:37:26Z","sig_algorithm":"ed25519","signature":"5a3978c26017daf4104adbb3e1c3099c5750157acbfc7242ece1815dc6740fe08a690291ce0afe42011e20cc565b5ebe64ec016bf658b5bab563a63337985c05","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_cf81dba1c68df3ac02de0ae45b4422b7c8c4775ed6034447632b1de7438efcc1"}}